Table 3 Angiogenic factors relating to anti-inflammatory and immunoregulatory of EPCs

From: Anti-inflammatory Prowess of endothelial progenitor cells in the realm of biology and medicine

Factor

EPC phenotype

Effect on inflammation and immunity

Involved pathway

Refs.

VEGF

CD34+/CD133+

↓ inflammation

↓ TLR4-NF-κB and PI3K-Akt

39,40,43

TGF-β

CD34+/CD133+

↓pro-inflammatory cytokine

↑ M2 and Treg

↓Th17

Unknown

45,48

FGF

ECFCs

↓IL-1, TNF-α, IL-6, and MCP-1

↓CD40

ERK1/2

NF-κB2

51,52

G-CSF/GM-CSF

CD34+/CD133+

↑ CD103+ DCs

↑M2, Th2 and Treg

↓TNF-α and IL-1β

↓T cell recruitment

Unknown

Epigenetic modifications

53,54

HGF

ECFCs

↑ IL-1Ra

↓TNF-α, IL-6, and IL-1β

↑CD14+ and IL-10

↓CD4+

 ↑ Th2

NF-κB

ERK1/2

20,57,61

PDGF

ECFCs

↑IL-4, IL-10, and IL-13

↓MMP-3, MMP-13, COX-2, IL-1, IL-6, and TNF- α

↑ M2 and Treg

NF-κB p65 translocation

PI3K/Akt-MEK/ERK

63,64